^
Association details:
| Biomarker: | ALK F1174C |
|---|---|
| Cancer: | Non Small Cell Lung Cancer |
| Drug: | Zykadia (ceritinib) (ALK inhibitor) |
| Direction: | Resistant |
Evidence:
Source:
Title:
Drug resistance in anaplastic lymphoma kinase-rearranged lung cancer
Excerpt:
G1202R, F1174C/L/V, and G1123S mutations have been found to be ceritinib‐resistant in an analysis of patients treated with ceritinib after crizotinib
DOI:
10.1111/cas.13504
